POP and Urinary Incontinence: First Line Medical Treatments

Incontinenza Medici in prima linea

Simple, convenient and safe, vaginal pessaries are among the most sought-after and appreciated solutions for the treatment of pelvic organ prolapse (POP) and urinary incontinence.

The global size of the pessary market was estimated at US $239.9 million in 2020 and weighs 6.4% on the global medical device market, valued at US $373 billion.
(Source: https://www.grandviewresearch.com/industry-analysis/vaginal-pessary-market-report)

Among the main factors contributing to the growth of the market, estimated at a CAGR of 9.2% from 2021 to 2028, there is an increasing prevalence of pelvic organ prolapse (POP), a growing geriatric population and therefore more prone to POP, easy product availability, a change in lifestyle and a rapid evolution of non-invasive treatment options that avoid corrective surgery.

Especially during the COVID-19 pandemic, pessaries were among the most chosen solutions as a temporary measure compared to corrective surgeries, which suffered significant delays.
(Source: https://www.grandviewresearch.com/industry-analysis/vaginal-pessary-market-report )

The Food Drug Administration (FDA) predicts that the number of women with POP will increase by 46% by 2050, reaching 4.9 million.
(Source: https://www.grandviewresearch.com/industry-analysis/vaginal-pessary-market-report)

As for stress urinary incontinence, another condition that requires the use of a pessary, is greater in women with a poor nutritional status which leads to a weakening of the pelvic muscles, especially the bladder.

Urinary incontinence affects 25-45% of women globally and the population exposed to it is growing significantly, especially in those countries where the average age is increasing, such as Belgium.
(Source: https://www.healthyagingpoll.org/reports-more/report/urinary-incontinence-inevitable-part-aging)

Uro-gynecological screening, targeted physiotherapy and non-invasive treatments, such as pessaries, are ways to prevent POP problems and urinary incontinence.

The company

For.me.sa. is an ISO 13485:2016 certified company, manufacturer and distributor of medical aids and devices on national and international territory.

The company’s core business and R&D engine is the gynecology segment which includes among its main products pessaries: class IIa and IIb medical devices for the containment of pelvic organ prolapse, urinary incontinence and the risk of preterm birth.

The pessary, available in different shapes, sizes and materials, is one of the medical devices used as conservative therapies and replace surgery.

Uro-gynecological screening, targeted physiotherapy and non-invasive treatments, such as pessaries, are the ways to prevent POP problems and urinary incontinence.

For.me.sa. cares about women’s health and for this very reason, thanks to its almost entirely female team, works every day to find innovative and competitive solutions aimed at improving the quality of life.